Total Payments
$6,742
2024 Payments
$23.14
Companies
31
Transactions
324
Medicare Patients
7,057
Medicare Billing
$385,807
Payment Breakdown by Category
Food & Beverage$5,935 (88.0%)
Travel$794.81 (11.8%)
Education$12.45 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,935 | 320 | 88.0% |
| Travel and Lodging | $794.81 | 3 | 11.8% |
| Education | $12.45 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,966 | 37 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,570 | 134 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $410.75 | 17 | $0 (2023) |
| PFIZER INC. | $403.04 | 18 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $355.30 | 22 | $0 (2019) |
| Amgen Inc. | $257.85 | 13 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $253.06 | 10 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $249.33 | 8 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $247.13 | 12 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $164.35 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.14 | 1 | Novo Nordisk Inc ($23.14) |
| 2023 | $205.71 | 10 | Esperion Therapeutics, Inc. ($42.94) |
| 2022 | $560.93 | 25 | Novartis Pharmaceuticals Corporation ($156.60) |
| 2021 | $27.68 | 2 | Novartis Pharmaceuticals Corporation ($14.07) |
| 2020 | $313.45 | 23 | Novartis Pharmaceuticals Corporation ($118.23) |
| 2019 | $1,714 | 119 | Novartis Pharmaceuticals Corporation ($513.40) |
| 2018 | $2,695 | 90 | BOSTON SCIENTIFIC CORPORATION ($1,342) |
| 2017 | $1,202 | 54 | Novartis Pharmaceuticals Corporation ($433.31) |
All Payment Transactions
324 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Diabetes | ||||||
| 06/26/2023 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Cardiology | ||||||
| 06/19/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/12/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/08/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/24/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Diabetes | ||||||
| 04/10/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Cardio-renal | ||||||
| 04/03/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/27/2023 | Philips Electronics North America Corporation | (5091) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $24.19 | General |
| Category: Medical Device | ||||||
| 01/30/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 01/09/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/19/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/19/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $3.57 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/12/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Diabetes | ||||||
| 12/05/2022 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $59.56 | General |
| Category: WATCHMAN_IC | ||||||
| 11/14/2022 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2022 | PFIZER INC. | ELIQUIS (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/20/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/12/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $34.07 | General |
| 10/06/2022 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $14.84 | General |
| Category: Rheumatology | ||||||
| 09/30/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: DIABETES | ||||||
| 08/22/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/09/2022 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Genetic Disease | ||||||
| 08/08/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 707 | 755 | $175,058 | $38,728 |
| 2022 | 14 | 1,788 | 2,263 | $441,482 | $104,549 |
| 2021 | 15 | 2,151 | 2,729 | $504,129 | $122,026 |
| 2020 | 12 | 2,411 | 2,883 | $517,522 | $120,504 |
Total Patients
7,057
Total Services
8,630
Medicare Billing
$385,807
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 191 | 202 | $67,468 | $16,008 | 23.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 93 | 95 | $58,330 | $12,637 | 21.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 95 | 97 | $22,601 | $5,160 | 22.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 28 | 28 | $7,224 | $1,634 | 22.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 162 | 166 | $11,786 | $1,626 | 13.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 125 | 154 | $4,620 | $1,006 | 21.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 13 | 13 | $3,029 | $658.68 | 21.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 243 | 409 | $136,606 | $36,069 | 26.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 162 | 167 | $102,538 | $25,571 | 24.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 287 | 299 | $69,667 | $17,019 | 24.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 92 | 92 | $23,736 | $5,709 | 24.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 553 | 664 | $19,920 | $4,429 | 22.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 238 | 350 | $24,850 | $3,800 | 15.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 23 | $10,304 | $3,162 | 30.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 19 | 19 | $9,671 | $2,091 | 21.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 30 | 30 | $8,294 | $1,670 | 20.1% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 14 | 24 | $5,304 | $1,393 | 26.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 47 | 47 | $8,225 | $832.67 | 10.1% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2022 | 11 | 36 | $4,248 | $814.16 | 19.2% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2022 | 14 | 45 | $5,940 | $797.20 | 13.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 11 | 11 | $4,048 | $635.70 | 15.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 47 | 47 | $8,131 | $555.74 | 6.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 267 | 499 | $166,666 | $46,838 | 28.1% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 388 | 400 | $93,200 | $23,267 | 25.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 143 | 146 | $89,644 | $21,882 | 24.4% |
About Dr. Barry Arkin, MD
Dr. Barry Arkin, MD is a Cardiovascular Disease healthcare provider based in Brockton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417904202.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barry Arkin, MD has received a total of $6,742 in payments from pharmaceutical and medical device companies, with $23.14 received in 2024. These payments were reported across 324 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,935).
As a Medicare-enrolled provider, Arkin has provided services to 7,057 Medicare beneficiaries, totaling 8,630 services with total Medicare billing of $385,807. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Brockton, MA
- Active Since 05/28/2006
- Last Updated 02/25/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1417904202
Products in Payments
- WATCHMAN (Device) $1,907
- ENTRESTO (Drug) $1,439
- ELIQUIS (Drug) $428.57
- XARELTO (Drug) $410.75
- PRALUENT (Drug) $249.33
- PRALUENT ALIROCUMAB INJECTION (Biological) $240.06
- BRILINTA (Drug) $149.10
- LifeVest (Device) $144.15
- CHANTIX (Drug) $142.48
- Repatha (Biological) $141.77
- LEQVIO (Drug) $130.98
- PRADAXA (Drug) $129.88
- JARDIANCE (Drug) $123.18
- Corlanor (Drug) $116.08
- PRALUENT (Biological) $115.24
- Ozempic (Drug) $105.98
- ONPATTRO (Drug) $87.15
- CardioMEMS HF System (Device) $63.82
- WATCHMAN Access System (Device) $59.56
- VYNDAQEL (Drug) $45.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brockton
Sumon Roy, Md, MD
Cardiovascular Disease — Payments: $37,482
Cardiovascular Disease $37,482
Bruce Kriegel, Md, MD
Cardiovascular Disease — Payments: $13,668
Cardiovascular Disease $13,668
Gary Miller, M.d, M.D
Cardiovascular Disease — Payments: $13,649
Cardiovascular Disease $13,649
Benoy Zachariah, Md, MD
Cardiovascular Disease — Payments: $8,683
Cardiovascular Disease $8,683
Syed Tahir, Md, MD
Cardiovascular Disease — Payments: $5,461
Cardiovascular Disease $5,461
Jean-Pierre Geagea, M.d, M.D
Cardiovascular Disease — Payments: $2,917
Cardiovascular Disease $2,917